RBC Capital Sees Tough Road Ahead Following Orexigen Therapeutics' (OREX) Takeda Partnership Termination; Cuts PT to $0.60

Go back to RBC Capital Sees Tough Road Ahead Following Orexigen Therapeutics' (OREX) Takeda Partnership Termination; Cuts PT to $0.60
Orexigen Therapeutics, Inc. (NASDAQ: OREX) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $4.75 
Open $0.04    52 Week Low $0.35 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $-1.02 
Volume 74,385